The Asia Pacific Hernia Mesh Devices Market would witness market growth of 7.9% CAGR during the forecast period (2023-2030). In the year 2021, the Asia Pacific market's volume surged to 1,221.8 thousand units, showcasing a growth of 9.0% (2019-2022).
The high prevalence of hernia and improved patient outcomes through meshes, reducing operative and recovery time, contribute to the expansion of the market. The high incidence rate of hernia generates demand for effective hernia mesh devices, which is anticipated to drive market expansion. In addition, using meshes in hernia repair reduces the possibility of recurrence and alleviates pain, which is anticipated to accelerate market growth.
Hernia mesh device advancements in technology have accelerated in recent years. To address the issues that arise during the laparoscopic procedure advances such as articulating fixation devices and self-fixating (gripping) mesh are being developed. In addition, these devices provide surgeons with improved access to abdominal wall weak spots and the ability to securely position mesh at the desired body site, thereby fostering market expansion.
The utilization of 3D printing technology has enabled the creation of customized hernia mesh devices tailored to the patient's specific anatomy. These devices provide an optimal fit, reducing the risk of complications. Biologic meshes, derived from natural sources such as porcine or bovine tissue, are gaining popularity. They have the advantage of being fully absorbed by the body over time, which lead to reduced long-term complications. Traditional fixation devices, such as sutures or tacks, can cause discomfort or complications for patients. Bioabsorbable fixation devices are becoming more common as they naturally dissolve over time, eliminating the need for removal.
As per NLM, Australia has experienced a precipitous increase in incisional and ventral hernia repair (IVHR) surgeries over the last twenty years, particularly for primary ventral hernias. The rise in IVHR surgeries has led to the development of customized mesh solutions tailored to the patient's anatomy in Australia. These personalized mesh devices aim to provide better fit and improved outcomes in Australia. Mesh manufacturers in Australia must cater to these specific requirements. As these surgeries are popular in Australia, the region will likely witness ongoing innovation, product development, and improved patient care. Due to these factors, the market in the Asia Pacific region is estimated to grow in upcoming years.
The China market dominated the Asia Pacific Hernia Mesh Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $490.6 Million by 2030. The Japan market is registering a CAGR of 7.1% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 8.5% during (2023 - 2030).
Based on Type, the market is segmented into Synthetic and Biologic. Based on Hernia Type, the market is segmented into Inguinal Hernia, Incisional Hernia, Femoral Hernia, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Global Hernia Mesh Devices Market is Predict to reach USD 8.2 Billion by 2030, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton Dickinson and Company, Johnson & Johnson, W. L. Gore & Associates, Inc., Atrium Medical Corporation (Getinge AB), B. Braun Melsungen AG, Baxter International, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Integra LifeSciences Holdings Corporation, and Herniamesh S.r.l.By Type (Volume, thousand units, USD Million, 2019-2030)
By Hernia Type (Volume, thousand units, USD Million, 2019-2030)
By Country (Volume, thousand units, USD Million, 2019-2030)
Our team of dedicated experts can provide you with attractive expansion opportunities for your business.
Unique Offerings 